JP Morgan Private Wealth Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$394K Sell
1,985
-1,951
-50% -$492K ﹤0.01% 1346
2023
Q2
$1.28M Sell
3,936
-934
-19% -$267K 0.01% 698
2023
Q1
$1.14M Buy
4,870
+250
+5% +$63.2K ﹤0.01% 1111
2022
Q4
$1.16M Buy
4,620
+154
+3% +$32.8K ﹤0.01% 1078
2022
Q3
$792K Sell
4,466
-1,095
-20% -$220K ﹤0.01% 1249
2022
Q2
$1.02M Sell
5,561
-1,595
-22% -$318K ﹤0.01% 1143
2022
Q1
$1.84M Sell
7,156
-134
-2% -$30.6K ﹤0.01% 938
2021
Q4
$1.68M Sell
7,290
-889
-11% -$217K ﹤0.01% 986
2021
Q3
$1.91M Sell
8,179
-1,827
-18% -$381K ﹤0.01% 927
2021
Q2
$1.93M Buy
10,006
+7,748
+343% +$1.54M 0.01% 896
2021
Q1
$467K Sell
2,258
-1,739
-44% -$370K ﹤0.01% 1341
2020
Q4
$752K Buy
+3,997
New +$654K ﹤0.01% 1114

Other funds holding INSP

JP Morgan Private Wealth Advisors's INSP Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Inspire Medical Systems (INSP) stake by 50% in Q3 2023, selling an estimated $492K and leaving 1,985 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #1346.

JP Morgan Private Wealth Advisors first reported a position in INSP in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.93M in Q2 2021. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 1,985 shares of Inspire Medical Systems worth $394K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 1,951 Inspire Medical Systems shares in Q3 2023, an estimated $492K.
  • Inspire Medical Systems made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1346 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Inspire Medical Systems in Q4 2020 and has held it in 12 quarters since.
  • JP Morgan Private Wealth Advisors's Inspire Medical Systems position peaked at $1.93M in Q2 2021.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.